Steroidal Contraceptives

---

Use of combined OCP can reduce risk of endometrial cancer up to

---

A. 15%
B. 27%
C. 50%
D. 65%

---

---

Mode of action of OCP does not include

---

A. Inhibition of ovulation
B. Hyperplasia of endometrium
C. Viscid and scanty cervical mucus
D. Inhibits FSH rise and prevents follicular growth

---

---

Contraindications for prescribing OCP are all except

---

A. Smokers

B. Tuberculosis

C. Sickle cell disease

D. history of migraine

---

---

Not true of Progesterone Only Pill is

---

A. Drospirenone has anti-mineralocorticoid activity.
B. More effective in treating polycystic ovary syndrome
C. Pill of choice after bariatric surgeries
D. Can be taken continuously without a hormone-free period

---

---

Monitoring for serum potassium level is required for pills containing

---

A. Desogestrel
B. Drospirenone
C. Levonorgestrel
D. Norgestimate

---

---

Acne can be avoided by taking the OCP containing

---

A. Levonorgestrel 

B. Desogestrel 

C. Norgestimate

D. Norethindrone acetate

---

---

In shorts

---

• Currently, there are three types of oral contraceptive pills: combined estrogen-progesterone, progesterone-only, and continuous or extended use pill.
• Approximately 25% of women aged 15 to 44 who currently use contraception reported using the pill as their method of choice.
• Progesterone is the hormone that prevents pregnancy, and the estrogen component controls menstrual bleeding.
• OCP’s can be used to address other health conditions, particularly menstrual-related disorders such as menstrual pain, irregular menstruation, fibroids, endometriosis-related pain, and menstrual-related migraines
• Combined OC use decreases the risk of ovarian cancer by 27%
• OCs have also been reported to reduce the risk of colon cancer by 18%
• Women who have two or more risk factors for cardiovascular diseases such as older age, diabetes, hypertension, or smoking should also not use COC as the risk outweighs benefits

---